
    
      Study design Imatinib: starting at day -3: 600mg/day; continuous administration In
      combination with cytarabine: continuous iv/24h: 100mg/m² ; 7 days and daunorubicine: 4 levels

      level 1: 0

      level 2: 15mg/m² ; 3 days

      level 3: 30mg/m² ; 3 days

      level 4: 45mg/m² ; 3 days
    
  